NewsBenzingaLakefront Biotherapeutics: EPS del terzo trimestre €(0,04) batte la stima di €(0,19), ricavi €7,569 milioni mancano la stima di €8,680 milioni Lakefront Biotherapeutics: EPS del terzo trimestre €(0,04) batte la stima di €(0,19), ricavi €7,569 milioni mancano la stima di €8,680 milioni Benzinga 2026.11.11 21:13 (GMT+0) Open on Benzinga Other news Wolfe Research Initiates Coverage On Monster Beverage with Outperform Rating Druckenmiller Buys Miners, Warns '27 Could Be 'Disappointing' Wolfe Research Initiates Coverage On Keurig Dr Pepper with Outperform Rating, Announces Price Target of $42 Wolfe Research Initiates Coverage On PepsiCo with Peer Perform Rating BTIG Reiterates Neutral on FuboTVto Neutral BTIG Reiterates Buy on MARA Holdings, Maintains $27 Price Target
Wolfe Research Initiates Coverage On Keurig Dr Pepper with Outperform Rating, Announces Price Target of $42